Titan Biotech Stock Screener | Share Price & Fundamental Analysis
TITANBIO
Specialty Chemicals
Screen Titan Biotech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹1092.90
▲
11.45 (1.06%)
Market Cap
₹878.38 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
5.43
EPS (TTM)
₹26.06
Dividend Yield
0.18%
Debt to Equity
0.04
52W High
₹1199.35
52W Low
₹391.45
Operating Margin
17.00%
Profit Margin
14.29%
Revenue (TTM)
₹56.00
EBITDA
₹11.00
Net Income
₹8.00
Total Assets
₹175.00
Total Equity
₹153.00
Titan Biotech Share Price History - Stock Screener Chart
Screen TITANBIO historical share price movements with interactive charts. Analyze price trends and patterns.
Titan Biotech Company Profile - Fundamental Screener
Screen Titan Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TITANBIO shares.
Sector
Chemicals
Industry
Specialty Chemicals
Sub-Sector
Specialty Chemicals
Segment
E
ISIN
INE150C01011
Titan Biotech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TITANBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 175 | 157 | 135 | 108 | 101 | 76 | 65 | 57 | 52 | 40 |
| Current Assets | 79 | 73 | 68 | 64 | 59 | 44 | 35 | 29 | 30 | 24 |
| Fixed Assets | 57 | 52 | 36 | 35 | 34 | 31 | 29 | 14 | 13 | 11 |
| Liabilities | ||||||||||
| Total Liabilities | 175 | 157 | 135 | 108 | 101 | 76 | 65 | 57 | 52 | 40 |
| Current Liabilities | 4 | 4 | 4 | 5 | 9 | 14 | 15 | 20 | 16 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 153 | 134 | 110 | 86 | 73 | 42 | 34 | 26 | 24 | 23 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 145 | 125 | 102 | 78 | 61 | 31 | 24 | 17 | 15 | 14 |
Screen TITANBIO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56 | 47 | 37 | 40 | 40 | 44 | 40 | 46 | 44 | 35 | 37 | 31 | 43 | 35 | 33 |
| Expenses | 45 | 38 | 31 | 33 | 32 | 35 | 33 | 35 | 35 | 27 | 30 | 26 | 31 | 27 | 26 |
| EBITDA | 11 | 10 | 6 | 6 | 8 | 9 | 8 | 11 | 9 | 8 | 7 | 4 | 11 | 8 | 8 |
| Operating Profit % | 17.00% | 19.00% | 13.00% | 13.00% | 19.00% | 19.00% | 18.00% | 23.00% | 20.00% | 23.00% | 19.00% | 14.00% | 25.00% | 23.00% | 23.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 8 | 5 | 5 | 7 | 8 | 6 | 10 | 8 | 7 | 6 | 4 | 11 | 8 | 7 |
| Tax | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 3 | 2 | 1 | 1 | 0 | 1 | 0 | 2 |
| Net Profit | 8 | 7 | 4 | 4 | 7 | 6 | 5 | 7 | 7 | 6 | 5 | 3 | 9 | 8 | 5 |
| EPS | 9.40 | 8.30 | 4.90 | 5.31 | 8.10 | 7.74 | 6.05 | 8.68 | 7.89 | 7.47 | 6.07 | 3.95 | 11.04 | 9.08 | 6.03 |
Titan Biotech Cash Flow Screener - Liquidity Fundamentals
Screen TITANBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 20 | 21 | 21 | 22 | 19 | 6 | 6 | 2 | 0 | 5 |
| Investing Activities | -10 | -20 | -21 | -16 | -5 | -2 | -4 | -6 | -8 | -5 |
| Financing Activities | -8 | -3 | -2 | -4 | -11 | -4 | 0 | 0 | 9 | 2 |
| Net Cash Flow | 2 | -2 | -2 | 2 | 4 | 0 | 1 | -3 | 1 | 2 |
Screen TITANBIO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 55.88% | 55.88% | 55.78% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.03% | 0.03% | 0.23% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.20% | 29.44% | 29.65% | 30.06% | 30.11% | 29.97% | 29.43% | 31.82% |
| Other Holding | 14.91% | 14.65% | 14.54% | 13.84% | 14.01% | 14.15% | 14.69% | 12.31% |
| Shareholder Count | 16,370 | 16,328 | 16,040 | 15,876 | 15,850 | 15,700 | 16,038 | 18,752 |
Titan Biotech Dividend Screener - Share Yield Analysis
Screen TITANBIO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹2.00 | 0.18% |
| 2024-March | ₹2.00 | 0.47% |
| 2023-March | ₹1.80 | 0.34% |
| 2022-March | ₹1.50 | 0.76% |
| 2021-March | ₹1.50 | 0.57% |
| 2020-March | ₹1.00 | 0.54% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.75 | 1.67% |
| 2017-March | ₹0.75 | 1.19% |
| 2016-March | ₹0.00 | 0.00% |
Titan Biotech Index Membership - Market Screener Classification
Screen TITANBIO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Titan Biotech Market Events Screener - Corporate Actions
Screen TITANBIO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 2.00 /share | 102.73% | ||
| Dividend | ₹ 1.50 /share | 5.48% | ||
| Dividend | ₹ 1.80 /share | 41.88% | ||
| Dividend | ₹ 2.00 /share | 14.63% | ||
| Annual General Meeting | NA | 14.27% | ||
| Dividend | ₹ 1.50 /share | -15.22% | ||
| Annual General Meeting | NA | 112.48% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -7.75% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.29% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.55% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.10% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -4.87% |
Titan Biotech Competitors Screener - Peer Comparison
Screen TITANBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 148,505 | 66.09 | 13,388 | 6.91% | 2,096 | 45.48 |
| SRF | 91,643 | 56.63 | 14,826 | 12.13% | 1,251 | 67.30 |
| Gujarat Fluorochemicals | 39,497 | 58.36 | 4,853 | 10.61% | 546 | 57.34 |
| Navin Fluorine International | 30,127 | 67.43 | 2,393 | 12.83% | 289 | 52.86 |
| Himadri Speciality Chemical | 23,863 | 37.00 | 4,664 | 10.33% | 555 | 61.18 |
| Deepak Nitrite | 22,917 | 42.75 | 8,366 | 7.84% | 697 | 62.87 |
| Atul | 17,639 | 31.46 | 5,692 | 18.99% | 499 | 55.33 |
| BASF | 17,019 | 45.00 | 15,339 | 10.81% | 479 | 36.03 |
| Vinati Organics | 16,382 | 37.14 | 2,293 | 18.24% | 405 | 44.88 |
| Anupam Rasayan | 15,276 | 68.19 | 1,449 | -3.77% | 160 | 72.09 |
Titan Biotech Company Announcements - News Screener
Screen TITANBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Closure of Trading Window | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-29 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-29 | Corporate Action-Intimation of Sub division / Stock Split | View |
| 2025-11-29 | Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th November 2025 | View |
| 2025-11-25 | Board Meeting Intimation for Proposal For Alteration In The Share Capital Of The Company By Sub-Division / Split Of Existing Equity Shares | View |
| 2025-11-25 | Closure of Trading Window | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-11 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-04 | Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025. | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 | View |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-27 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-26 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 | View |